ORGANOVO HOLDINGS
Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.
ORGANOVO HOLDINGS
Industry:
Biotechnology Medical Therapeutics
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.organovo.com
Total Employee:
51+
Status:
Active
Contact:
(858)550-9994
Email Addresses:
[email protected]
Total Funding:
112.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Eric Del Balso
Eric Del Balso investment in Post-IPO Equity - Organovo Holdings
SternAegis
SternAegis investment in Post-IPO Equity - Organovo Holdings
Spencer Trask & Co
Spencer Trask & Co investment in Post-IPO Equity - Organovo Holdings
Michael Brams
Michael Brams investment in Series A - Organovo Holdings
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-18 | Organovo Welcomes New Sr. Vice President of Strategy and Business Development |
Official Site Inspections
http://www.organovo.com Semrush global rank: 2.35 M Semrush visits lastest month: 7.92 K
- Host name: 52.18.197.104.bc.googleusercontent.com
- IP address: 104.197.18.52
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Organovo Holdings"
Who We Are - Organovo, Inc.
We Are Focused on the Rapid Clinical and Commercial Development of New Medicines Based on Our Exceptional 3D Human Tissue Model Technology. Organovo creates human models of …See details»
Leadership Team - Organovo, Inc.
With decades of leadership experience in the life science industry, our team fosters an ethos of innovation to develop regenerative medicine therapies aimed at treating a range of serious …See details»
Organovo - Wikipedia
Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D bioprinting technology) for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting. See details»
Organovo Holdings - Crunchbase Company Profile & Funding
Organovo's technology for creating 3D bioprinted tissues that mimic human biology for disease modeling, drug discovery, and therapeutic applications. Novel Drug to Undisclosed Target A …See details»
Organovo Holdings, Inc. - LinkedIn
Organovo Holdings, Inc. Biotechnology Research San Diego, California 11,031 followers Discovering drugs using highly customized human tissues as living, dynamic models of human …See details»
Investor Presentation (December 2023) - Organovo Holdings, Inc.
Quoted, or reproduced for distributionoutside the organization without prior written approval from Organovo Holdings, Inc. Company Presentation. ... • Organovo creates exceptional 3D models …See details»
Organovo - Pioneering 3D Human Tissues
Pioneering 3D Human Tissues for Drug Discovery. Organovo is at the forefront of 3D bioprinting technology, revolutionizing drug discovery and development with innovative human tissue …See details»
Organovo Holdings, Inc. (ONVO) Company Profile & Overview
Nov 21, 2024 Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes …See details»
Organovo Appoints Dr. Kirk Malloy to Board of Directors
SAN DIEGO, Dec. 8, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo "), a three-dimensional biology company focused on delivering breakthrough 3D …See details»
Board of Directors - Organovo, Inc.
She began her career in June 2000 at Arthur Andersen LLP. Ms. Milhous served on the membership committee of Athena San Diego, a professional women’s leadership organization …See details»
Organovo On Track to Establish Human 3D Disease Model in …
Nov 30, 2021 According to the Biotechnology Innovation Organization’s 2021 report, only 7.9% of drugs that enter clinical trials are approved for human use. Organovo believes that it can …See details»
Organovo On Track to Establish Human 3D Disease Model in …
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to …See details»
Organovo Holdings - Funding, Financials, Valuation & Investors
Organovo Holdings is registered under the ticker NASDAQ:ONVO . Their stock opened with $4.50 in its Aug 8, 2016 IPO. Stock Symbol NASDAQ:ONVO ; Valuation at IPO $331.6M; Money …See details»
Regenerative Medicine for Vascular Health - ir.organovo.com
Certain statements contained in this presentation or in other documents of Organovo Holdings, Inc. (the “Company” or “Organovo”) and of any of its affiliates, along with certain statements …See details»
About - Organovo, Inc.
© 2024 Organovo Holdings Inc. 11555 Sorrento Valley Road, Suite 100 San Diego, CA 92121See details»
Organovo Holdings, Inc. (ONVO) - Stock Analysis
Nov 21, 2024 About ONVO. Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue …See details»
Organovo On Track to Establish Human 3D Disease Model in
Nov 30, 2021 Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human …See details»
Publications - Organovo, Inc.
Shelby M. King, Senior Research Scientist, Organovo. July 2016. Modeling compound-induced fibrogenesis in vitro using 3D bioprinted human liver tissues Leah Norona, UNC Chapel Hill. …See details»
Organovo Highlights FXR314 Combination Therapy Potential and …
Nov 8, 2023 Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for …See details»